Biofrontera Settles Skin Therapy IP Suit On Eve Of Trial
Biofrontera Inc. and rival skin treatment developer Dusa Pharmaceuticals Inc. settled a patent dispute Monday, one day before the infringement claims were set to go to trial....To view the full article, register now.
Already a subscriber? Click here to view full article